ArticleBiomedicines2024

Real-World Case Series of Efgartigimod for Japanese Generalized Myasthenia Gravis: Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom Control.

Shingo Konno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.